About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Current Opinion in Pharmacology
›
Top Articles
Current Opinion in Pharmacology
Pharmacology
5.1
(top 3%)
Impact Factor
5.5
(top 3%)
extended IF
138
(top 2%)
H-Index
1.7K
authors
2.2K
papers
104.7K
citations
7.2K
citing journals
86.3K
citing authors
Most Cited Articles of Current Opinion in Pharmacology
Title
Year
Citations
Dissecting components of reward: 'liking', 'wanting', and learning
2009
1.2K
Vitamin D: modulator of the immune system
2010
770
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
2006
755
NMDA receptor subunits: function and pharmacology
2007
655
Role of neurotrophic factors in depression
2007
540
N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency
2007
442
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises
2008
439
Novel trends in high-throughput screening
2009
434
The mechanisms of action of gabapentin and pregabalin
2006
421
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression
2002
410
Reward system and addiction: what dopamine does and doesn't do
2007
398
Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine
2005
398
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
2008
396
Natural products in anticancer therapy
2001
390
Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity
2009
381
GABA-based therapeutic approaches: GABAA receptor subtype functions
2006
379
Targeting mTOR signaling for cancer therapy
2003
369
Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress
2007
368
Update on the antibiotic resistance crisis
2014
365
Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology
2005
362
PD-1/PD-L1 inhibitors
2015
358
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease
2004
344
Renaissance in antibacterial discovery from actinomycetes
2008
340
Neurobiology of craving, conditioned reward and relapse
2005
331
Targeting the androgen receptor pathway in prostate cancer
2008
330
previous
2007
2008
2009
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.